Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Challenges of diagnosing and managing polymyalgia rheumatica: a multi-methods study in UK general practice.

Helliwell T, Muller S, Hider SL, Zwierska I, Lawton S, Richardson J, Mallen C.

Br J Gen Pract. 2018 Nov;68(676):e783-e793. doi: 10.3399/bjgp18X699557.

PMID:
30348883
2.

The INCLUDE study: INtegrating and improving Care for patients with infLammatory rheUmatological DisordErs in the community; identifying multimorbidity: Protocol for a pilot randomized controlled trial.

Hider SL, Bucknall M, Cooke K, Cooke K, Finney AG, Goddin D, Healey EL, Hennings S, Herron D, Jinks C, Lewis M, Machin A, Mallen C, Wathall S, Chew-Graham CA.

J Comorb. 2018 Aug 2;8(1):2235042X18792373. doi: 10.1177/2235042X18792373. eCollection 2018.

3.

Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?

Scott IC, Hider SL, Scott DL.

Drug Saf. 2018 Jul;41(7):645-653. doi: 10.1007/s40264-018-0651-5. Review.

PMID:
29500799
4.

Challenges of diagnosis and management of giant cell arteritis in general practice: a multimethods study.

Helliwell T, Muller S, Hider SL, Prior JA, Richardson JC, Mallen CD.

BMJ Open. 2018 Feb 3;8(2):e019320. doi: 10.1136/bmjopen-2017-019320.

5.

Factors Influencing Allopurinol Initiation in Primary Care.

Clarson LE, Hider SL, Belcher J, Roddy E, Mallen CD.

Ann Fam Med. 2017 Nov;15(6):557-560. doi: 10.1370/afm.2137.

6.

Association between characteristics of pain and stiffness and the functional status of patients with incident polymyalgia rheumatica from primary care.

Cawley A, Prior JA, Muller S, Helliwell T, Hider SL, Dasgupta B, Barraclough K, Mallen CD.

Clin Rheumatol. 2018 Jun;37(6):1639-1644. doi: 10.1007/s10067-017-3730-6. Epub 2017 Jun 20.

7.

How common is depression in patients with polymyalgia rheumatica?

Vivekanantham A, Blagojevic-Bucknall M, Clarkson K, Belcher J, Mallen CD, Hider SL.

Clin Rheumatol. 2018 Jun;37(6):1633-1638. doi: 10.1007/s10067-017-3691-9. Epub 2017 Jun 1.

PMID:
28573368
8.

Incident acute pseudogout and prior bisphosphonate use: Matched case-control study in the UK-Clinical Practice Research Datalink.

Roddy E, Muller S, Paskins Z, Hider SL, Blagojevic-Bucknall M, Mallen CD.

Medicine (Baltimore). 2017 Mar;96(12):e6177. doi: 10.1097/MD.0000000000006177.

9.

Patients' views on the causes of their polymyalgia rheumatica: a content analysis of data from the PMR Cohort Study.

Tshimologo M, Saunders B, Muller S, Mallen CD, Hider SL.

BMJ Open. 2017 Jan 25;7(1):e014301. doi: 10.1136/bmjopen-2016-014301.

10.

Reconsultation, self-reported health status and costs following treatment at a musculoskeletal Clinical Assessment and Treatment Service (CATS): a 12-month prospective cohort study.

Roddy E, Jordan KP, Oppong R, Chen Y, Jowett S, Dawes P, Hider SL, Packham J, Stevenson K, Zwierska I, Hay EM.

BMJ Open. 2016 Oct 12;6(10):e011735. doi: 10.1136/bmjopen-2016-011735.

11.

Characterising those with incident polymyalgia rheumatica in primary care: results from the PMR Cohort Study.

Muller S, Hider SL, Helliwell T, Lawton S, Barraclough K, Dasgupta B, Zwierska I, Mallen CD.

Arthritis Res Ther. 2016 Sep 7;18:200. doi: 10.1186/s13075-016-1097-8.

12.

Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study.

Ahmed N, Prior JA, Chen Y, Hayward R, Mallen CD, Hider SL.

Clin Rheumatol. 2016 Dec;35(12):3069-3073. Epub 2016 Aug 2.

PMID:
27485152
13.

The Importance of Linking Primary and Secondary Electronic Medical Records.

Muller S, Hider SL, Mallen CD.

J Rheumatol. 2016 Jun;43(6):1252. doi: 10.3899/jrheum.151336. Epub 2016 Jun 1. No abstract available.

PMID:
27252497
14.

An algorithm to identify rheumatoid arthritis in primary care: a Clinical Practice Research Datalink study.

Muller S, Hider SL, Raza K, Stack RJ, Hayward RA, Mallen CD.

BMJ Open. 2015 Dec 23;5(12):e009309. doi: 10.1136/bmjopen-2015-009309.

15.

What does a primary care annual review for RA include? A national GP survey.

Hider SL, Blagojevic-Bucknall M, Whittle R, Clarkson K, Mangat N, Stack R, Raza K, Mallen CD.

Clin Rheumatol. 2016 Aug;35(8):2137-2138. doi: 10.1007/s10067-015-3093-9. Epub 2015 Oct 10. No abstract available.

PMID:
26454814
16.

Mapping patients' experiences from initial symptoms to gout diagnosis: a qualitative exploration.

Liddle J, Roddy E, Mallen CD, Hider SL, Prinjha S, Ziebland S, Richardson JC.

BMJ Open. 2015 Sep 14;5(9):e008323. doi: 10.1136/bmjopen-2015-008323.

17.

Foot problems in people with gout in primary care: baseline findings from a prospective cohort study.

Roddy E, Muller S, Rome K, Chandratre P, Hider SL, Richardson J, Blagojevic-Bucknall M, Mallen CD.

J Foot Ankle Res. 2015 Jul 23;8:31. doi: 10.1186/s13047-015-0090-9. eCollection 2015.

18.

Fatigue as a precursor to polymyalgia rheumatica: an explorative retrospective cohort study.

Green DJ, Muller S, Mallen CD, Hider SL.

Scand J Rheumatol. 2015 May;44(3):219-23. doi: 10.3109/03009742.2014.959047. Epub 2014 Nov 4.

PMID:
25366389
19.

Response to: 'Risk of vascular disease with gout: overadjustment of the statistical analyses?' by van Durme et al.

Clarson L, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD.

Ann Rheum Dis. 2015 Jan;74(1):e10. doi: 10.1136/annrheumdis-2014-206723. Epub 2014 Oct 28. No abstract available.

PMID:
25351520
20.

Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink.

Clarson LE, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD.

Ann Rheum Dis. 2015 Apr;74(4):642-7. doi: 10.1136/annrheumdis-2014-205252. Epub 2014 Aug 27.

21.

Obesity and comorbidity are independently associated with a failure to achieve remission in patients with established rheumatoid arthritis.

Ellerby N, Mattey DL, Packham J, Dawes P, Hider SL.

Ann Rheum Dis. 2014 Nov;73(11):e74. doi: 10.1136/annrheumdis-2014-206254. Epub 2014 Aug 8. No abstract available.

PMID:
25107560
22.

Risk of vascular events in patients with polymyalgia rheumatica.

Hancock AT, Mallen CD, Muller S, Belcher J, Roddy E, Helliwell T, Hider SL.

CMAJ. 2014 Sep 16;186(13):E495-501. doi: 10.1503/cmaj.140266. Epub 2014 Jul 28.

23.

Pain location matters: the impact of leg pain on health care use, work disability and quality of life in patients with low back pain.

Hider SL, Whitehurst DG, Thomas E, Foster NE.

Eur Spine J. 2015 Mar;24(3):444-51. doi: 10.1007/s00586-014-3355-2. Epub 2014 May 18.

PMID:
24838505
24.

Association of polymyalgia rheumatica with socioeconomic status in primary care: a cross-sectional observational study.

Hayward RA, Rathod T, Muller S, Hider SL, Roddy E, Mallen CD.

Arthritis Care Res (Hoboken). 2014 Jun;66(6):956-60.

25.

Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis.

Clarson LE, Chandratre P, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD.

Eur J Prev Cardiol. 2015 Mar;22(3):335-43. doi: 10.1177/2047487313514895. Epub 2013 Nov 26. Review.

26.

Cardiovascular screening in rheumatoid arthritis: a cross-sectional primary care database study.

Monk HL, Muller S, Mallen CD, Hider SL.

BMC Fam Pract. 2013 Oct 10;14:150. doi: 10.1186/1471-2296-14-150.

27.

Health-related quality of life in gout: a systematic review.

Chandratre P, Roddy E, Clarson L, Richardson J, Hider SL, Mallen CD.

Rheumatology (Oxford). 2013 Nov;52(11):2031-40. doi: 10.1093/rheumatology/ket265. Epub 2013 Aug 11. Review.

28.

The association of gout with socioeconomic status in primary care: a cross-sectional observational study.

Hayward RA, Rathod T, Roddy E, Muller S, Hider SL, Mallen CD.

Rheumatology (Oxford). 2013 Nov;52(11):2004-8. doi: 10.1093/rheumatology/ket262. Epub 2013 Jul 30.

29.

Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database.

Muller S, Hider SL, Belcher J, Helliwell T, Mallen CD.

Ann Rheum Dis. 2014 Oct;73(10):1769-73. doi: 10.1136/annrheumdis-2013-203465. Epub 2013 Jul 10.

30.

Polymyalgia rheumatica: diagnosis, prescribing, and monitoring in general practice.

Helliwell T, Hider SL, Mallen CD.

Br J Gen Pract. 2013 May;63(610):e361-6. doi: 10.3399/bjgp13X667231.

31.

Musculoskeletal clinical assessment and treatment services at the primary-secondary care interface: an observational study.

Roddy E, Zwierska I, Jordan KP, Dawes P, Hider SL, Packham J, Stevenson K, Hay EM.

Br J Gen Pract. 2013 Feb;63(607):e141-8. doi: 10.3399/bjgp13X663109.

32.

The impact of low back-related leg pain on outcomes as compared with low back pain alone: a systematic review of the literature.

Konstantinou K, Hider SL, Jordan JL, Lewis M, Dunn KM, Hay EM.

Clin J Pain. 2013 Jul;29(7):644-54. doi: 10.1097/AJP.0b013e31826f9a52. Review.

PMID:
23328336
33.

An unorthodox approach to calculating sample size.

Muller S, Hider SL, Helliwell T, Mallen CD.

BMJ. 2012 Oct 2;345:e6586. doi: 10.1136/bmj.e6586. No abstract available.

PMID:
23033422
34.

Diagnosis and management of giant cell arteritis.

Barraclough K, Mallen CD, Helliwell T, Hider SL, Dasgupta B.

Br J Gen Pract. 2012 Jun;62(599):329-30. doi: 10.3399/bjgp12X649313. No abstract available.

35.

Diagnosis and management of polymyalgia rheumatica.

Helliwell T, Hider SL, Barraclough K, Dasgupta B, Mallen CD.

Br J Gen Pract. 2012 May;62(598):275-6. doi: 10.3399/bjgp12X641636. No abstract available.

36.

Association between polymyalgia rheumatica and vascular disease: a systematic review.

Hancock AT, Mallen CD, Belcher J, Hider SL.

Arthritis Care Res (Hoboken). 2012 Sep;64(9):1301-5. doi: 10.1002/acr.21712. Review.

37.

Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients.

Owen SA, Hider SL, Martin P, Bruce IN, Barton A, Thomson W.

Pharmacogenomics J. 2013 Jun;13(3):227-34. doi: 10.1038/tpj.2012.7. Epub 2012 Mar 27.

38.

Fibromyalgia in patients with rheumatoid arthritis: driven by depression or joint damage?

Kapoor SR, Hider SL, Brownfield A, Mattey DL, Packham JC.

Clin Exp Rheumatol. 2011 Nov-Dec;29(6 Suppl 69):S88-91. Epub 2012 Jan 3.

PMID:
22243554
39.

Clinical course, characteristics and prognostic indicators in patients presenting with back and leg pain in primary care. The ATLAS study protocol.

Konstantinou K, Beardmore R, Dunn KM, Lewis M, Hider SL, Sanders T, Jowett S, Somerville S, Stynes S, van der Windt DA, Vogel S, Hay EM.

BMC Musculoskelet Disord. 2012 Jan 20;13:4. doi: 10.1186/1471-2474-13-4.

40.

Development of an assessment schedule for patients with low back-associated leg pain in primary care: a Delphi consensus study.

Konstantinou K, Hider SL, Vogel S, Beardmore R, Somerville S.

Eur Spine J. 2012 Jul;21(7):1241-9. doi: 10.1007/s00586-011-2057-2. Epub 2011 Nov 4.

41.

MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms.

Owen SA, Lunt M, Bowes J, Hider SL, Bruce IN, Thomson W, Barton A.

Pharmacogenomics J. 2013 Apr;13(2):137-47. doi: 10.1038/tpj.2011.42. Epub 2011 Sep 20.

PMID:
21931346
42.

Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort.

Owen SA, Lunt M, Hider SL, Bruce IN, Barton A, Thomson W.

Arthritis Rheum. 2010 Dec;62(12):3827-9. doi: 10.1002/art.27754. No abstract available.

43.

The Staffordshire arthritis, musculoskeletal, and back assessment (SAMBA) study: a prospective observational study of patient outcome following referral to a primary-secondary care musculoskeletal interface service.

Roddy E, Zwierska I, Dawes P, Hider SL, Jordan KP, Packham J, Stevenson K, Hay E; SAMBA team.

BMC Musculoskelet Disord. 2010 Apr 8;11:67. doi: 10.1186/1471-2474-11-67.

44.

Prescription and comorbidity screening following consultation for acute gout in primary care.

Roddy E, Mallen CD, Hider SL, Jordan KP.

Rheumatology (Oxford). 2010 Jan;49(1):105-11. doi: 10.1093/rheumatology/kep332. Epub 2009 Nov 17.

PMID:
19920095
45.

Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic.

Hider SL, Tanveer W, Brownfield A, Mattey DL, Packham JC.

Rheumatology (Oxford). 2009 Sep;48(9):1152-4. doi: 10.1093/rheumatology/kep170. Epub 2009 Jul 16.

PMID:
19608723
46.

Biomarkers of oxidant stress, insulin sensitivity and endothelial activation in rheumatoid arthritis: a cross-sectional study of their association with accelerated atherosclerosis.

Pemberton PW, Ahmad Y, Bodill H, Lokko D, Hider SL, Yates AP, Walker MG, Laing I, Bruce IN.

BMC Res Notes. 2009 May 9;2:83. doi: 10.1186/1756-0500-2-83.

47.

Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX.

Hider SL, Thomson W, Mack LF, Armstrong DJ, Shadforth M, Bruce IN.

Rheumatology (Oxford). 2008 Aug;47(8):1156-9. doi: 10.1093/rheumatology/ken182. Epub 2008 Jun 6.

48.

Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis?

Hider SL, Silman AJ, Thomson W, Lunt M, Bunn D, Symmons DP.

Ann Rheum Dis. 2009 Jan;68(1):57-62. doi: 10.1136/ard.2008.088237. Epub 2008 Feb 21.

49.

The pharmacogenetics of methotrexate.

Hider SL, Bruce IN, Thomson W.

Rheumatology (Oxford). 2007 Oct;46(10):1520-4. Epub 2007 Jun 24. Review.

PMID:
17586865
50.

Lung fibrosis in systemic sclerosis treated with a combination of ciclosporin and azathioprine.

Hider SL, Woodhead M, Taylor PM, Bruce IN.

Clin Exp Rheumatol. 2006 Mar-Apr;24(2):215. No abstract available.

PMID:
16762168

Supplemental Content

Loading ...
Support Center